Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, is pleased to announce the appointment of Giedrius Žunda as Chief Executive Officer effective from 3 December 2018.
Northway Biotechpharma will expand its existing manufacturing facility by adding a new line of bioreactors
